Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18413 | 487 | 31.0 | 65% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 618 | 13204 | HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ACQUIRED VON WILLEBRAND SYNDROME | Author keyword | 40 | 62% | 8% | 41 |
| 2 | ACQUIRED VON WILLEBRAND DISEASE | Author keyword | 15 | 62% | 3% | 16 |
| 3 | ACQUIRED VON WILLEBRANDS SYNDROME | Author keyword | 8 | 100% | 1% | 5 |
| 4 | ACQUIRED VON WILLEBRANDS DISEASE | Author keyword | 7 | 67% | 1% | 6 |
| 5 | HEMOSTASIS HEMATOL | Address | 6 | 100% | 1% | 4 |
| 6 | AVWS | Author keyword | 2 | 67% | 0% | 2 |
| 7 | HEMOSTASIS THROMBOSIS VASC PATHOL | Address | 2 | 67% | 0% | 2 |
| 8 | ACQUIRED VON WILLEBRAND SYNDROME AVWS | Author keyword | 1 | 100% | 0% | 2 |
| 9 | ACQUIRED VONWILLEBRAND DISEASE | Author keyword | 1 | 100% | 0% | 2 |
| 10 | INHIBITOR TO VWF | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | II VONWILLEBRANDS DISEASE | 30 | 100% | 2% | 12 |
| 2 | ACQUIRED VONWILLEBRANDS DISEASE | 15 | 63% | 3% | 15 |
| 3 | REGRESSION FOLLOWING TREATMENT | 15 | 88% | 1% | 7 |
| 4 | FACTOR VIII ACTIVITY | 10 | 43% | 4% | 18 |
| 5 | VON WILLEBRANDS SYNDROME | 8 | 100% | 1% | 5 |
| 6 | CONTINUOUS FACTOR CONCENTRATE | 6 | 80% | 1% | 4 |
| 7 | VONWILLEBRANDS DISEASE | 5 | 10% | 9% | 45 |
| 8 | VONWILLEBRAND SYNDROME | 4 | 75% | 1% | 3 |
| 9 | BLEEDING GASTROINTESTINAL ANGIODYSPLASIA | 4 | 40% | 2% | 8 |
| 10 | PLATELET KINETICS | 2 | 44% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| How I treat the acquired von Willebrand syndrome | 2011 | 41 | 62 | 48% |
| Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic | 2007 | 77 | 50 | 70% |
| The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors | 2012 | 13 | 51 | 75% |
| Hypothyroidism and acquired von Willebrand's syndrome: a systematic review | 2008 | 22 | 43 | 91% |
| Pathophysiology of acquired von Willebrand disease: a concise review | 2011 | 13 | 71 | 62% |
| Acquired von Willebrand syndrome: Features and management | 2006 | 30 | 61 | 80% |
| Acquired von Willebrand disease | 2002 | 46 | 74 | 76% |
| Coagulation and fibrinolysis in thyroid dysfunction | 2009 | 12 | 41 | 78% |
| Acquired von Willebrand syndrome: An update | 2007 | 29 | 101 | 75% |
| Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management | 2001 | 70 | 110 | 74% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HEMOSTASIS HEMATOL | 6 | 100% | 0.8% | 4 |
| 2 | HEMOSTASIS THROMBOSIS VASC PATHOL | 2 | 67% | 0.4% | 2 |
| 3 | DIPARTIMENTO SCI BIOMED MORFOL | 1 | 15% | 1.2% | 6 |
| 4 | AGHIA SOPHIA CHILDRENS HOSP ENDOCRINOL METAB | 1 | 50% | 0.2% | 1 |
| 5 | ALUMNO CARRERA MED | 1 | 50% | 0.2% | 1 |
| 6 | CLIN EPIDEMIOL C9 P | 1 | 50% | 0.2% | 1 |
| 7 | CLIN MED SCI MOL INTERNAL MEDMINAMI K | 1 | 50% | 0.2% | 1 |
| 8 | CLIN PAEDIAT ONCOL SURG | 1 | 50% | 0.2% | 1 |
| 9 | HEMOSTASIS METAB DISORDERS | 1 | 50% | 0.2% | 1 |
| 10 | KLIN POLIKLIN OPHTHALMOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000156407 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD |
| 2 | 0.0000109007 | HYPOTHYROID MYOPATHY//HOFFMANNS SYNDROME//COCUK ENDOKRIN KLIN |
| 3 | 0.0000107612 | BIOCHEM PHYSIOL NUTR SCITORRE BIOL//HEPARIN LIKE ANTICOAGULANTS//IST PLURIDISCIPLINARE FISIOL UMANA |
| 4 | 0.0000092055 | SUBCLINICAL HYPOTHYROIDISM//HYPOTHYROIDISM//SUBCLINICAL HYPERTHYROIDISM |
| 5 | 0.0000090142 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN |
| 6 | 0.0000074649 | TAFI//CARBOXYPEPTIDASE U//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR |
| 7 | 0.0000067120 | ANGIODYSPLASIA//LOWER GASTROINTESTINAL BLEEDING//GASTROINTESTINAL TRACT HEMORRHAGE |
| 8 | 0.0000056241 | HYPOTYROIDISM//LIBERINS//UNSOLVABLE PROBLEMS |
| 9 | 0.0000055507 | PINK TEETH//EMERGENCY MED FORENS MED//NEOCRYSTALLIZATION |
| 10 | 0.0000053835 | CORONARY VASCULAR DISEASES//GAUSSIAN GRAPHICAL MODELING//IODINE BRINE |